Professor Kathleen Boyd

  • Professor of Health Economics, Director of research (Health Economics & Health Technology Assessment)

email: Kathleen.Boyd@glasgow.ac.uk

Rm 354, Clarice Pears Building, 90 Byres Rd,, Health Economics & Health Technology Assessment, School of Health & Wellbeing, Glasgow, G12 8TB

Import to contacts

ORCID iDhttps://orcid.org/0000-0002-9764-0113

Biography

I am a Professor of Health Economics with the Health Economics for Health Technology Assessment (HEHTA) group and Director of Research for the School of Health & Wellbeing at the University of Glasgow.

I lead the Economic Evaluation alongside the Clinical Trials theme within HEHTA, collaborating throughout the UK and internationally on health care research projects; leading the economic components regarding trial design, analysis of economic evaluations alongside clinical trials, incorporating modelling and economic analyses of complex and public health interventions. I lead the health economics aspects on multi-disciplinary research projects in a wide range of health and clinical areas such as smoking cessation, oncology, obstetrics, early years and child health, diagnostics, medical devices and public health.

I am a lead Health Economics Reviewer for the Scottish Medicines Consortium (SMC) New Drugs Committee, which directly informs decision making policy in Scotland. I have extensive experience in providing expert reviews for prestigious funding bodies such as National Institute for Health Research (NIHR), Medical Research Council (MRC) and Cancer Research UK, as well as funding panel membership. I am an advisory board member for the Beatson CRUK Clinical Trials Unit at Glasgow, and steering committee member for numerous NIHR research programme projects (NIHR HTA 152682; NIHR HTA 134350; NIHR HTA 134101; NIHR HA 127408; NIHR HSR 16/144/05 ) and the Academy of Medical Sciences Roundtable on Child Health Policy.

I have a BA (Hons) in Economics from the University of Strathclyde, an MSc in Economics and Health Economics from the School of Health and Related Research (ScHARR) at Sheffield University, a Pg Certificate in Academic Practice and a PhD in Health Economics from the University of Glasgow. 

 

Research interests

Methodological interests in HTA include:

  • Decision analytic modelling
  • Early stage / pre-trial modelling
  • Designing and undertaking economic evaluations alongside clinical trials
  • HTA for complex and public health interventions 
  • Value of Information Analysis

I have a track record of successful research grants from prestigious UK and international funding bodies working alongside world-leading clinical collaborators to design and undertake economic evaluations within a wide variety of health care areas including:

  • Oncology
  • Smoking cessation interventions
  • Obstetrics
  • Child health
  • mental Health
  • Social care interventions
  • Diagnostic test

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
Number of items: 81.

2024

Skivington, K. et al. (2024) A new framework for developing and evaluating complex interventions: Update of Medical Research Council guidance. International Journal of Nursing Studies, (doi: 10.1016/j.ijnurstu.2024.104705) (In Press)

Minnis, H. et al. (2024) Prioritising early childhood to promote the nation’s health, wellbeing and prosperity. Working Paper. Academy of Medical Sciences.

Murray, S. et al. (2024) Randomised placebo-controlled trial of antenatal corticosteroids for planned birth in twins (STOPPIT-3): study protocol. BMJ Open, 14(1), e078778. (doi: 10.1136/bmjopen-2023-078778) (PMID:38238048) (PMCID:PMC10806667)

2023

McMeekin, N. et al. (2023) Implementation of a national smoke-free prison policy: an economic evaluation within the Tobacco in Prisons (TIPs) study. Tobacco Control, 32(6), pp. 701-708. (doi: 10.1136/tobaccocontrol-2021-056991) (PMID:35256533) (PMCID:PMC7615232)

Heggie, R., Jaiswal, N. , McCartney, E. , Moss, J., Menne, T., Jones, B., Boyd, K. , Soulis, E., Hawkins, N. and Wu, O. (2023) Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation. Value in Health, (doi: 10.1016/j.jval.2023.09.2996) (PMID:37844662) (In Press)

Mcmeekin, N., Sinclair, L., Robinson-Smith, L., Mitchell, A., Bauld, L., Tappin, D. M. and Boyd, K. A. (2023) Financial incentives for quitting smoking in pregnancy: are they cost-effective. Addiction, 118(8), pp. 1445-1456. (doi: 10.1111/add.16176) (PMID:36843417)

Venson, R. , Maheshwari, A., Nelson, S. M. and Boyd, K. A. (2023) Setting a tariff for IVF and ICSI treatment: a cost analysis. Human Fertility, (doi: 10.1080/14647273.2023.2204409) (PMID:37300314) (Early Online Publication)

de Souza Cazarim, M., Cruz-Cazarim, E. L. C., Boyd, K. , Wu, O. and Nunes, A. A. (2023) Effect of medication therapy management by pharmaceutical care on blood pressure and cardiovascular risk in hypertension: a systematic review, meta-analysis, and meta-regression. Pharmaceuticals, 16(6), 845. (doi: 10.3390/ph16060845) (PMID:37375792) (PMCID:PMC10302324)

2022

Tappin, D. et al. (2022) Effect of financial voucher incentives provided with UK stop smoking services on the cessation of smoking in pregnant women (CPIT III): pragmatic, multicentre, single blinded, phase 3, randomised controlled trial. British Medical Journal, 379, e071522. (doi: 10.1136/bmj-2022-071522) (PMID:36261162) (PMCID:PMC9580214)

Hanna, C.R. , Lemmon, E., Hall, P.S., Ennis, H., Morris, E., McLoone, P. , Boyd, K.A. and Jones, R.J. (2022) Cancer trial impact: understanding implementation of the Short Course Oncology Treatment trial findings at a national level. Clinical Oncology, 34(9), pp. 554-560. (doi: 10.1016/j.clon.2022.03.012) (PMID:35370039)

Kohli-Lynch, C. N., Lewsey, J. , Boyd, K. A. , French, D. D., Jordan, N., Moran, A. E., Sattar, N. , Preiss, D. and Briggs, A. H. (2022) Beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease. Circulation, 145(17), pp. 1312-1323. (doi: 10.1161/CIRCULATIONAHA.121.057631) (PMID:35249370) (PMCID:PMC9022692)

Crawford, K. et al. (2022) The Best Services Trial (BeST?): a cluster randomised controlled trial comparing the clinical and cost-effectiveness of New Orleans Intervention Model with Services as Usual (SAU) for infants and young children entering care. Trials, 23, 122. (doi: 10.1186/s13063-022-06007-3) (PMID:35130937) (PMCID:PMC8819875)

Hunt, K. et al. (2022) Process and impact of implementing a smoke-free policy in prisons in Scotland: TIPs mixed-methods study. Public Health Research, 10(1), (doi: 10.3310/WGLF1204) (PMID:35129938)

2021

Tweed, E. J. et al. (2021) Evaluation of a national smoke-free prisons policy using medication dispensing: an interrupted time-series analysis. Lancet Public Health, 6(11), e795-e804. (doi: 10.1016/S2468-2667(21)00163-8) (PMID:34537108) (PMCID:PMC8554387)

Skivington, K. et al. (2021) A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. British Medical Journal, 374, n2061. (doi: 10.1136/bmj.n2061) (PMID:34593508)

Hanna, C. R. et al. (2021) Three versus six months of adjuvant doublet chemotherapy for patients with colorectal cancer: a multi-country cost-effectiveness and budget impact analysis. Clinical Colorectal Cancer, 20(3), pp. 236-244. (doi: 10.1016/j.clcc.2021.04.001) (PMID:33992542)

Skivington, K. et al. (2021) Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update. Health Technology Assessment, 25(57), (doi: 10.3310/hta25570) (PMID:34590577)

Stock, S. J. et al. (2021) A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study. Health Technology Assessment, 25(52), (doi: 10.3310/hta25520) (PMID:34498576)

Heggie, R., Boyd, K. and Wu, O. (2021) How has implementation been incorporated in health technology assessments in the United Kingdom? A systematic rapid review. Health Research Policy and Systems, 19, 118. (doi: 10.1186/s12961-021-00766-2)

Stock, S. J. et al. (2021) Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): a prospective cohort study and individual participant data meta-analysis. PLoS Medicine, 18(7), e1003686. (doi: 10.1371/journal.pmed.1003686) (PMID:34228732)

Stock, S. J. et al. (2021) Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol. BMJ Open, 11(5), e050452. (doi: 10.1136/bmjopen-2021-050452) (PMID:33947741) (PMCID:33947741)

Hanna, C. R. , Boyd, K. A. and Jones, R. J. (2021) Evaluating cancer research impact: lessons and examples from existing reviews on approaches to research impact assessment. Health Research Policy and Systems, 19, 36. (doi: 10.1186/s12961-020-00658-x) (PMID:33706777) (PMCID:PMC7953786)

Hanna, C. R. , Boyd, K. A. , Wincenciak, J. , Graham, J., Iveson, T., Jones, R. J. and Wilson, R. (2021) Do clinical trials change practice? A longitudinal, international assessment of colorectal cancer prescribing practices. Cancer Treatment and Research Communications, 28, 100445. (doi: 10.1016/j.ctarc.2021.100445) (PMID:34425469)

Turongkaravee, S., Jittikoon, J., Rochanathimoke, O., Boyd, K. , Wu, O. and Chaikledkaew, U. (2021) Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation. BMC Health Services Research, 21, 1042. (doi: 10.1186/s12913-021-07025-8) (PMID:34600523) (PMCID:PMC8487501)

2020

Mcmeekin, N., Sinclair, L., Bauld, L., Tappin, D. M. , Mitchell, A. and Boyd, K. A. (2020) A protocol for the economic evaluation of the Smoking Cessation in Pregnancy Incentives Trial (CPIT III). BMJ Open, 10, e038827. (doi: 10.1136/bmjopen-2020-038827)

Manca, F., Robinson, E., Dillon, J. F. and Boyd, K. A. (2020) Eradicating Hepatitis C: are novel screening strategies for people who inject drugs cost-effective? International Journal of Drug Policy, 82, 102811. (doi: 10.1016/j.drugpo.2020.102811) (PMID:32585583)

Hanna, C. R. , Gatting, L. P., Boyd, K. A. , Robb, K. A. and Jones, R. J. (2020) Evidencing the impact of cancer trials: insights from the 2014 UK Research Excellence Framework. Trials, 21, 486. (doi: 10.1186/s13063-020-04425-9) (PMID:32503612) (PMCID:PMC7275320)

Sinclair, L. et al. (2020) The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial. Trials, 21, 183. (doi: 10.1186/s13063-019-4042-8) (PMID:32059684) (PMCID:PMC7023794)

Heggie, R., Boyd, K. , Horne, M., Bruijn, M., Stock, S. and on behalf of the QUIDS research team, . (2020) When should we admit for preterm labour? An economic evaluation of the QUIDS prognostic model. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

Heggie, R., Wu, O. , Boyd, K. , Lee, M. M.Y., Petrie, M. C. , McEntegart, M. and Berry, C. (2020) Does routine invasive management benefit patients presenting with an acute coronary syndrome and a history of bypass surgery? The use of clinical outcomes compared with cost-effectiveness outcomes. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

2019

Iveson, T. et al. (2019) 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. Health Technology Assessment, 23(64), (doi: 10.3310/hta23640) (PMID:31852579)

Hunt, K. et al. (2019) Smoke-free prison policy development, implementation, and impact across the entire national prison service in Scotland (TIPs study): a three-phase, mixed methods natural experimental evaluation. Lancet, 394(S2), S15. (doi: 10.1016/S0140-6736(19)32812-0)

Dillon, J. F. et al. (2019) Intelligent Liver Function Testing (iLFT): A trial of automated diagnosis and staging of liver disease in Primary Care. Journal of Hepatology, 71(4), pp. 699-706. (doi: 10.1016/j.jhep.2019.05.033) (PMID:31226388)

Henderson, M. et al. (2019) Trial of healthy relationship initiatives for the very early years (THRIVE), evaluating Enhanced Triple P for Baby and Mellow Bumps for those with additional social and care needs during pregnancy and their infants who are at higher risk of maltreatment: study protocol for a randomised controlled trial. Trials, 20, 499. (doi: 10.1186/s13063-019-3571-5) (PMID:31412902) (PMCID:PMC6694522)

Hatton, M. Q.F. et al. (2019) Accelerated, dose escalated, sequential chemoradiotherapy in non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study. BMJ Open, 9(1), e019903. (doi: 10.1136/bmjopen-2017-019903) (PMID:30700475) (PMCID:PMC6352760)

Squires, H. and Boyd, K. (2019) Use of modelling in the economic evaluation of public health interventions. In: Edwards, R. T. and McIntosh, E. (eds.) Applied Health Economics for Public Health Practice and Research. Series: Handbooks in health economic evaluation. Oxford University Press. ISBN 9780198737483

2018

Robles-Zurita, J. A. et al. (2018) SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer. British Journal of Cancer, 119(11), pp. 1332-1338. (doi: 10.1038/s41416-018-0319-z) (PMID:30420616) (PMCID:PMC6265336)

Stock, S. J. et al. (2018) Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: individual participant data meta-analysis and health economic analysis. BMJ Open, 8(4), e020796. (doi: 10.1136/bmjopen-2017-020796) (PMID:29627817) (PMCID:PMC5892771)

Boyd, K. , Dillon, J., Inglis, S. and Rezaeihemami, M. (2018) Making Sense of Liver Function Tests: Is the Intelligent Liver Function Test (iLFT) Cost-Effective? The International Liver Congress 2018, Paris, France, 11-15 Apr 2018. ISBN 0168-8278 (doi: 10.1016/S0168-8278(18)31885-3)

Iveson, T. J. et al. (2018) 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. Lancet Oncology, 19(4), pp. 562-578. (doi: 10.1016/S1470-2045(18)30093-7) (PMID:29611518) (PMCID:PMC5883334)

Stock, S. J. et al. (2018) Study protocol: quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 2, UK Prospective Cohort Study. BMJ Open, 8(4), e020795. (doi: 10.1136/bmjopen-2017-020795) (PMID:29674373) (PMCID:PMC5914783)

Deidda, M. , Boyd, K. A. , Minnis, H. , Donaldson, J., Brown, K., Boyer, N. R.S. and McIntosh, E. (2018) Protocol for the economic evaluation of a complex intervention to improve the mental health of maltreated infants and children in foster care in the UK (The BeST? services trial). BMJ Open, 8(3), e020066. (doi: 10.1136/bmjopen-2017-020066) (PMID:29540420)

Dillon, J. F. et al. (2018) A pilot evaluation of an intelligent liver diagnostic pathway: Making sense of LFTs for patients, GPs and the NHS in Scotland. Project Report. Chief Scientist Office, Edinburgh.

2017

Haghpanahan, H. , Boyd, K.A. , Mackay, D.F. , Mcintosh, E. , Pell, J. and Haw, S. (2017) The Effectiveness and Cost-Effectiveness of Tobacco Control Mass Media Campaigns In Scotland. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. (doi: 10.1016/j.jval.2017.08.007)

Heggie, R., Boyd, K. , Stock, S. and Bruijn, M. (2017) How Should We Test For Pre-Term Labour? An Economic Model And Cost-Effectiveness Analysis. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. A600. (doi: 10.1016/j.jval.2017.08.1143)

Kohli-Lynch, C.N. , Boyd, K. , Briggs, A. and Delles, C. (2017) A Framework for the Cost-Effectiveness Analysis of Novel Biomarker Testing in Cardiovascular Disease. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. A404-A405. (doi: 10.1016/j.jval.2017.08.040)

Rezaei Hemami, M., Boyd, K.A. , Inglis, S.K., Dow, E. and Dilon, J.F. (2017) Cost Effectivness Of Inteligent Liver Function Test(ILFT) For Investigating Patients With Abnormal Liver Function Test. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. A597. (doi: 10.1016/j.jval.2017.08.1129)

Iveson, T. et al. (2017) Final DFS Results of the SCOT study: An International Phase III Randomised (1:1) Non-Inferiority Trial Comparing 3 Versus 6 Months of Oxaliplatin Based Adjuvant Chemotherapy for Colorectal Cancer. 42nd ESMO 2017 Congress, Madrid, Spain, 8-12 Sept 2017.

Lawless, C.A. et al. (2017) ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). UNSPECIFIED S80-S81. (doi: 10.1016/S0169-5002(17)30221-0)

2016

Minnis, H. et al. (2016) Protocol 15PRT/6090:The Best Services Trial (BeST?): effectiveness and cost-effectiveness of the New Orleans Intervention Model for Infant Mental Health − NCT02653716. Lancet Protocols,

Boyd, K. , Tappin, D. M. and Bauld, L. (2016) Cost-effectiveness of financial incentives for smoking cessation in pregnancy. Addiction, 111(6), pp. 115-117. (doi: 10.1111/add.13374) (PMID:27157899)

Wu, O. , Boyd, K. , Paul, J. , McCartney, E. , Ritchie, M., Mellon, D., Kelly, L., Dixon-Hughes, J. and Moss, J. (2016) Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation. British Journal of Cancer, 114(9), pp. 979-985. (doi: 10.1038/bjc.2016.76) (PMID:27092784)

Graham, J.S., Boyd, K. , Coxon, F.Y., Wall, L.R., Eatock, M.M., Maughan, T.S., Highley, M., Soulis, E., Conway, F. and Evans, T. (2016) A phase II study of capecitabine and oxalplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract. BMC Research Notes, 9, 161. (doi: 10.1186/s13104-015-1778-4) (PMID:26969121) (PMCID:PMC4788848)

Boyd, K. A. , Briggs, A. H. , Bauld, L., Sinclair, L. and Tappin, D. (2016) Are financial incentives cost-effective to support smoking cessation during pregnancy? Addiction, 111(2), pp. 360-370. (doi: 10.1111/add.13160) (PMID:26370095)

Boyd, K. A. , Balogun, M. O. and Minnis, H. (2016) Development of a radical foster care intervention in Glasgow, Scotland. Health Promotion International, 31(3), pp. 665-673. (doi: 10.1093/heapro/dav041) (PMID:26045403)

2015

Boyd, K. A. , Jones, R. J. , Paul, J. , Birrell, F., Briggs, A. H. and Leung, H. Y. (2015) Decision-analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer. BMJ Open, 5(10), e007925. (doi: 10.1136/bmjopen-2015-007925) (PMID:26482768) (PMCID:PMC4611206)

Boyd, K. and McIntosh, E. (2015) Bronchiolitis of infancy discharge study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation. Health Technology Assessment, 19(71), pp. 1-172. (doi: 10.3310/hta19710) (PMID:26364905)

Cunningham, S. et al. (2015) Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial. Lancet, 386(9998), pp. 1041-1048. (doi: 10.1016/S0140-6736(15)00163-4) (PMID:26382998) (PMCID:PMC4673090)

Tappin, D. et al. (2015) Financial incentives for smoking cessation in pregnancy: a randomised controlled trial. British Medical Journal, 350, h134. (doi: 10.1136/bmj.h134) (PMID:25627664)

2014

Turner-Halliday, F., Watson, N. , Boyer, N. R.S. , Boyd, K. A. and Minnis, H. (2014) The feasibility of a randomised controlled trial of Dyadic Developmental Psychotherapy. BMC Psychiatry, 14, 347. (doi: 10.1186/s12888-014-0347-z) (PMID:25551365) (PMCID:PMC4302079)

Boyer, N. , Boyd, K. A. , Turner-Halliday, F., Watson, N. and Minnis, H. (2014) Examining the feasibility of an economic analysis of dyadic developmental psychotherapy for children with maltreatment associated psychiatric problems in the United Kingdom. BMC Psychiatry, 14, 346. (doi: 10.1186/s12888-014-0346-0) (PMID:25492801) (PMCID:PMC4299309)

Tappin, D. et al. (2014) Financial incentives for smoking cessation during pregnancy: a randomised controlled trial. Lancet, 384, S4. (doi: 10.1016/S0140-6736(14)62130-9)

Boyd, K.A. , Briggs, A.H. , Bauld, L., Sinclair, L. and Tappin, D. (2014) Are financial incentives cost-effective for smoking cessation amongst pregnant women? European Journal of Public Health, 24(S2), p. 146. (doi: 10.1093/eurpub/cku162.090)

Tappin, D. , Bauld, L., Purves, D., Boyd, K. A. , Sinclair, L., MacAskill, S., McKell, J., Friel, B., McConnachie, A. and Coleman, T. (2014) Cessation in Pregnancy Incentives Trial (CPIT): a phase II trial in Scotland 2011-2013. European Journal of Public Health, 24(S2), p. 183. (doi: 10.1093/eurpub/cku163.071)

Boyd, K.A. , Jones, R.J. , Paul, J. , Briggs, A. and Leung, H.Y. (2014) A decision-analytic cost-effectiveness model to compare treatment options for radiation recurrent prostate cancer against androgen deprivation therapy. British Journal of Surgery, 101(s4), p. 59. (doi: 10.1002/bjs.9510)

2013

Pritchett, R. et al. (2013) A feasibility randomised controlled trial of the New Orleans intervention of infant mental health: a study protocol. Scientific World Journal, 2013(838042), (doi: 10.1155/2013/838042)

Boyd, K. and Briggs, A. (2013) Statistical issues with trial data and economic modeling for cost-effectiveness evaluation. In: Tang, W. and Tu, X. (eds.) Modern Clinical Trial Analysis. Series: Applied bioinformatics and biostatistics in cancer research. Springer-Verlag: New York, NY, USA, pp. 149-166. ISBN 9781461443216 (doi: 10.1007/978-1-4614-4322-3_6)

2012

Ferguson, J., Docherty, G., Bauld, L., Lewis, S., Lorgelly, P., Boyd, K.A. , McEwen, A. and Coleman, T. (2012) Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial. British Medical Journal, 344, e1696. (doi: 10.1136/bmj.e1696)

Roberts, N.J., Boyd, K. , Briggs, A.H. , Caress, A.L. and Partridge, M.R. (2012) Nurse led versus lay educators support for those with asthma in primary care: a costing study. BMC Pulmonary Medicine, 12(52), (doi: 10.1186/1471-2466-12-52)

Tappin, D.M. et al. (2012) The cessation in pregnancy incentives trial (CPIT): study protocol for a randomized controlled trial. Trials, 13(113), (doi: 10.1186/1745-6215-13-113) (PMID:22818493) (PMCID:PMC3482147)

Watterson, A., Little, D., Young, J.A., Murray, F., Doi, L., Boyd, K.A. and Azim, E. (2012) Scoping a public health impact assessment of aquaculture with particular reference to tilapia in the UK. ISRN Public Health, 2012, pp. 1-18. (doi: 10.5402/2012/203796)

2011

Boyd, K.A. , Briggs, A.H. , Fenwick, E., Norrie, J. and Stock, S. (2011) Power and sample size for cost-effectiveness analysis: fFN neonatal screening. Contemporary Clinical Trials, 32(6), pp. 893-901. (doi: 10.1016/j.cct.2011.07.007)

Brush, J. et al. (2011) The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Health Technology Assessment, 15(35), pp. 1-192. (doi: 10.3310/hta15350)

Bauld, L., Boyd, K. A. , Briggs, A. H. , Chesterman, J., Ferguson, J., Judge, K. and Hiscock, R. (2011) One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine and Tobacco Research, 13(2), pp. 135-145. (doi: 10.1093/ntr/ntq222)

Boyd, K.A. , Briggs, A. , Paul, J. , Iveson, T., Midgely, R., Harkin, A., Bates, G., Alexander, L. and Cassidy, J. (2011) Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting? Trials, 12, A41. (doi: 10.1186/1745-6215-12-S1-A41)

2010

Boyd, K.A. , Fenwick, E. and Briggs, A. (2010) Using an iterative approach to economic evaluation in the drug development process. Drug Development Research, 71(8), pp. 470-477. (doi: 10.1002/ddr.20421)

Young, J.A., Little, D.C., Watterson, A., Murray, F., Boyd, K. , Leschen, W. and Kodithuwakku, S. (2010) Growing green: the emergent role of non-tilapia attributes in marketing tilapia. Aquaculture: Economics and Management, 14(1), pp. 63-79. (doi: 10.1080/13657300903566886)

2009

Boyd, K.A. and Briggs, A.H. (2009) Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow. Addiction, 104(2), pp. 317-325. (doi: 10.1111/j.1360-0443.2008.02449.x)

Belton, B., Little, D. and Grady, K. (2009) Is responsible aquaculture sustainable aquaculture? WWF and the eco-certification of Tilapia. Society and Natural Resources, 22(9), pp. 840-855. (doi: 10.1080/08941920802506257)

2008

Little, D.C., Murray, F.J., Azim, E., Leschen, W., Boyd, K. , Watterson, A. and Young, J.A. (2008) Options for producing a warm-water fish in the UK: limits to 'Green Growth'? Trends in Food Science and Technology, 19(5), pp. 255-264. (doi: 10.1016/j.tifs.2007.12.003)

Watterson, A., Little, D., Young, J.A., Boyd, K., Azim, E. and Murray, F. (2008) Towards integration of environmental and health impact assessments for wild capture fishing and farmed fish with particular reference to public health and occupational health dimensions. International Journal of Enviromental Health Research, 5(4), pp. 258-277. (doi: 10.3390/ijerph5040258)

This list was generated on Thu Apr 18 22:55:55 2024 BST.
Jump to: Articles | Book Sections | Research Reports or Papers | Conference or Workshop Item
Number of items: 81.

Articles

Skivington, K. et al. (2024) A new framework for developing and evaluating complex interventions: Update of Medical Research Council guidance. International Journal of Nursing Studies, (doi: 10.1016/j.ijnurstu.2024.104705) (In Press)

Murray, S. et al. (2024) Randomised placebo-controlled trial of antenatal corticosteroids for planned birth in twins (STOPPIT-3): study protocol. BMJ Open, 14(1), e078778. (doi: 10.1136/bmjopen-2023-078778) (PMID:38238048) (PMCID:PMC10806667)

McMeekin, N. et al. (2023) Implementation of a national smoke-free prison policy: an economic evaluation within the Tobacco in Prisons (TIPs) study. Tobacco Control, 32(6), pp. 701-708. (doi: 10.1136/tobaccocontrol-2021-056991) (PMID:35256533) (PMCID:PMC7615232)

Heggie, R., Jaiswal, N. , McCartney, E. , Moss, J., Menne, T., Jones, B., Boyd, K. , Soulis, E., Hawkins, N. and Wu, O. (2023) Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation. Value in Health, (doi: 10.1016/j.jval.2023.09.2996) (PMID:37844662) (In Press)

Mcmeekin, N., Sinclair, L., Robinson-Smith, L., Mitchell, A., Bauld, L., Tappin, D. M. and Boyd, K. A. (2023) Financial incentives for quitting smoking in pregnancy: are they cost-effective. Addiction, 118(8), pp. 1445-1456. (doi: 10.1111/add.16176) (PMID:36843417)

Venson, R. , Maheshwari, A., Nelson, S. M. and Boyd, K. A. (2023) Setting a tariff for IVF and ICSI treatment: a cost analysis. Human Fertility, (doi: 10.1080/14647273.2023.2204409) (PMID:37300314) (Early Online Publication)

de Souza Cazarim, M., Cruz-Cazarim, E. L. C., Boyd, K. , Wu, O. and Nunes, A. A. (2023) Effect of medication therapy management by pharmaceutical care on blood pressure and cardiovascular risk in hypertension: a systematic review, meta-analysis, and meta-regression. Pharmaceuticals, 16(6), 845. (doi: 10.3390/ph16060845) (PMID:37375792) (PMCID:PMC10302324)

Tappin, D. et al. (2022) Effect of financial voucher incentives provided with UK stop smoking services on the cessation of smoking in pregnant women (CPIT III): pragmatic, multicentre, single blinded, phase 3, randomised controlled trial. British Medical Journal, 379, e071522. (doi: 10.1136/bmj-2022-071522) (PMID:36261162) (PMCID:PMC9580214)

Hanna, C.R. , Lemmon, E., Hall, P.S., Ennis, H., Morris, E., McLoone, P. , Boyd, K.A. and Jones, R.J. (2022) Cancer trial impact: understanding implementation of the Short Course Oncology Treatment trial findings at a national level. Clinical Oncology, 34(9), pp. 554-560. (doi: 10.1016/j.clon.2022.03.012) (PMID:35370039)

Kohli-Lynch, C. N., Lewsey, J. , Boyd, K. A. , French, D. D., Jordan, N., Moran, A. E., Sattar, N. , Preiss, D. and Briggs, A. H. (2022) Beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease. Circulation, 145(17), pp. 1312-1323. (doi: 10.1161/CIRCULATIONAHA.121.057631) (PMID:35249370) (PMCID:PMC9022692)

Crawford, K. et al. (2022) The Best Services Trial (BeST?): a cluster randomised controlled trial comparing the clinical and cost-effectiveness of New Orleans Intervention Model with Services as Usual (SAU) for infants and young children entering care. Trials, 23, 122. (doi: 10.1186/s13063-022-06007-3) (PMID:35130937) (PMCID:PMC8819875)

Hunt, K. et al. (2022) Process and impact of implementing a smoke-free policy in prisons in Scotland: TIPs mixed-methods study. Public Health Research, 10(1), (doi: 10.3310/WGLF1204) (PMID:35129938)

Tweed, E. J. et al. (2021) Evaluation of a national smoke-free prisons policy using medication dispensing: an interrupted time-series analysis. Lancet Public Health, 6(11), e795-e804. (doi: 10.1016/S2468-2667(21)00163-8) (PMID:34537108) (PMCID:PMC8554387)

Skivington, K. et al. (2021) A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. British Medical Journal, 374, n2061. (doi: 10.1136/bmj.n2061) (PMID:34593508)

Hanna, C. R. et al. (2021) Three versus six months of adjuvant doublet chemotherapy for patients with colorectal cancer: a multi-country cost-effectiveness and budget impact analysis. Clinical Colorectal Cancer, 20(3), pp. 236-244. (doi: 10.1016/j.clcc.2021.04.001) (PMID:33992542)

Skivington, K. et al. (2021) Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update. Health Technology Assessment, 25(57), (doi: 10.3310/hta25570) (PMID:34590577)

Stock, S. J. et al. (2021) A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study. Health Technology Assessment, 25(52), (doi: 10.3310/hta25520) (PMID:34498576)

Heggie, R., Boyd, K. and Wu, O. (2021) How has implementation been incorporated in health technology assessments in the United Kingdom? A systematic rapid review. Health Research Policy and Systems, 19, 118. (doi: 10.1186/s12961-021-00766-2)

Stock, S. J. et al. (2021) Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): a prospective cohort study and individual participant data meta-analysis. PLoS Medicine, 18(7), e1003686. (doi: 10.1371/journal.pmed.1003686) (PMID:34228732)

Stock, S. J. et al. (2021) Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol. BMJ Open, 11(5), e050452. (doi: 10.1136/bmjopen-2021-050452) (PMID:33947741) (PMCID:33947741)

Hanna, C. R. , Boyd, K. A. and Jones, R. J. (2021) Evaluating cancer research impact: lessons and examples from existing reviews on approaches to research impact assessment. Health Research Policy and Systems, 19, 36. (doi: 10.1186/s12961-020-00658-x) (PMID:33706777) (PMCID:PMC7953786)

Hanna, C. R. , Boyd, K. A. , Wincenciak, J. , Graham, J., Iveson, T., Jones, R. J. and Wilson, R. (2021) Do clinical trials change practice? A longitudinal, international assessment of colorectal cancer prescribing practices. Cancer Treatment and Research Communications, 28, 100445. (doi: 10.1016/j.ctarc.2021.100445) (PMID:34425469)

Turongkaravee, S., Jittikoon, J., Rochanathimoke, O., Boyd, K. , Wu, O. and Chaikledkaew, U. (2021) Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation. BMC Health Services Research, 21, 1042. (doi: 10.1186/s12913-021-07025-8) (PMID:34600523) (PMCID:PMC8487501)

Mcmeekin, N., Sinclair, L., Bauld, L., Tappin, D. M. , Mitchell, A. and Boyd, K. A. (2020) A protocol for the economic evaluation of the Smoking Cessation in Pregnancy Incentives Trial (CPIT III). BMJ Open, 10, e038827. (doi: 10.1136/bmjopen-2020-038827)

Manca, F., Robinson, E., Dillon, J. F. and Boyd, K. A. (2020) Eradicating Hepatitis C: are novel screening strategies for people who inject drugs cost-effective? International Journal of Drug Policy, 82, 102811. (doi: 10.1016/j.drugpo.2020.102811) (PMID:32585583)

Hanna, C. R. , Gatting, L. P., Boyd, K. A. , Robb, K. A. and Jones, R. J. (2020) Evidencing the impact of cancer trials: insights from the 2014 UK Research Excellence Framework. Trials, 21, 486. (doi: 10.1186/s13063-020-04425-9) (PMID:32503612) (PMCID:PMC7275320)

Sinclair, L. et al. (2020) The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial. Trials, 21, 183. (doi: 10.1186/s13063-019-4042-8) (PMID:32059684) (PMCID:PMC7023794)

Iveson, T. et al. (2019) 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. Health Technology Assessment, 23(64), (doi: 10.3310/hta23640) (PMID:31852579)

Hunt, K. et al. (2019) Smoke-free prison policy development, implementation, and impact across the entire national prison service in Scotland (TIPs study): a three-phase, mixed methods natural experimental evaluation. Lancet, 394(S2), S15. (doi: 10.1016/S0140-6736(19)32812-0)

Dillon, J. F. et al. (2019) Intelligent Liver Function Testing (iLFT): A trial of automated diagnosis and staging of liver disease in Primary Care. Journal of Hepatology, 71(4), pp. 699-706. (doi: 10.1016/j.jhep.2019.05.033) (PMID:31226388)

Henderson, M. et al. (2019) Trial of healthy relationship initiatives for the very early years (THRIVE), evaluating Enhanced Triple P for Baby and Mellow Bumps for those with additional social and care needs during pregnancy and their infants who are at higher risk of maltreatment: study protocol for a randomised controlled trial. Trials, 20, 499. (doi: 10.1186/s13063-019-3571-5) (PMID:31412902) (PMCID:PMC6694522)

Hatton, M. Q.F. et al. (2019) Accelerated, dose escalated, sequential chemoradiotherapy in non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study. BMJ Open, 9(1), e019903. (doi: 10.1136/bmjopen-2017-019903) (PMID:30700475) (PMCID:PMC6352760)

Robles-Zurita, J. A. et al. (2018) SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer. British Journal of Cancer, 119(11), pp. 1332-1338. (doi: 10.1038/s41416-018-0319-z) (PMID:30420616) (PMCID:PMC6265336)

Stock, S. J. et al. (2018) Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: individual participant data meta-analysis and health economic analysis. BMJ Open, 8(4), e020796. (doi: 10.1136/bmjopen-2017-020796) (PMID:29627817) (PMCID:PMC5892771)

Iveson, T. J. et al. (2018) 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. Lancet Oncology, 19(4), pp. 562-578. (doi: 10.1016/S1470-2045(18)30093-7) (PMID:29611518) (PMCID:PMC5883334)

Stock, S. J. et al. (2018) Study protocol: quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 2, UK Prospective Cohort Study. BMJ Open, 8(4), e020795. (doi: 10.1136/bmjopen-2017-020795) (PMID:29674373) (PMCID:PMC5914783)

Deidda, M. , Boyd, K. A. , Minnis, H. , Donaldson, J., Brown, K., Boyer, N. R.S. and McIntosh, E. (2018) Protocol for the economic evaluation of a complex intervention to improve the mental health of maltreated infants and children in foster care in the UK (The BeST? services trial). BMJ Open, 8(3), e020066. (doi: 10.1136/bmjopen-2017-020066) (PMID:29540420)

Minnis, H. et al. (2016) Protocol 15PRT/6090:The Best Services Trial (BeST?): effectiveness and cost-effectiveness of the New Orleans Intervention Model for Infant Mental Health − NCT02653716. Lancet Protocols,

Boyd, K. , Tappin, D. M. and Bauld, L. (2016) Cost-effectiveness of financial incentives for smoking cessation in pregnancy. Addiction, 111(6), pp. 115-117. (doi: 10.1111/add.13374) (PMID:27157899)

Wu, O. , Boyd, K. , Paul, J. , McCartney, E. , Ritchie, M., Mellon, D., Kelly, L., Dixon-Hughes, J. and Moss, J. (2016) Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation. British Journal of Cancer, 114(9), pp. 979-985. (doi: 10.1038/bjc.2016.76) (PMID:27092784)

Graham, J.S., Boyd, K. , Coxon, F.Y., Wall, L.R., Eatock, M.M., Maughan, T.S., Highley, M., Soulis, E., Conway, F. and Evans, T. (2016) A phase II study of capecitabine and oxalplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract. BMC Research Notes, 9, 161. (doi: 10.1186/s13104-015-1778-4) (PMID:26969121) (PMCID:PMC4788848)

Boyd, K. A. , Briggs, A. H. , Bauld, L., Sinclair, L. and Tappin, D. (2016) Are financial incentives cost-effective to support smoking cessation during pregnancy? Addiction, 111(2), pp. 360-370. (doi: 10.1111/add.13160) (PMID:26370095)

Boyd, K. A. , Balogun, M. O. and Minnis, H. (2016) Development of a radical foster care intervention in Glasgow, Scotland. Health Promotion International, 31(3), pp. 665-673. (doi: 10.1093/heapro/dav041) (PMID:26045403)

Boyd, K. A. , Jones, R. J. , Paul, J. , Birrell, F., Briggs, A. H. and Leung, H. Y. (2015) Decision-analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer. BMJ Open, 5(10), e007925. (doi: 10.1136/bmjopen-2015-007925) (PMID:26482768) (PMCID:PMC4611206)

Boyd, K. and McIntosh, E. (2015) Bronchiolitis of infancy discharge study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation. Health Technology Assessment, 19(71), pp. 1-172. (doi: 10.3310/hta19710) (PMID:26364905)

Cunningham, S. et al. (2015) Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial. Lancet, 386(9998), pp. 1041-1048. (doi: 10.1016/S0140-6736(15)00163-4) (PMID:26382998) (PMCID:PMC4673090)

Tappin, D. et al. (2015) Financial incentives for smoking cessation in pregnancy: a randomised controlled trial. British Medical Journal, 350, h134. (doi: 10.1136/bmj.h134) (PMID:25627664)

Turner-Halliday, F., Watson, N. , Boyer, N. R.S. , Boyd, K. A. and Minnis, H. (2014) The feasibility of a randomised controlled trial of Dyadic Developmental Psychotherapy. BMC Psychiatry, 14, 347. (doi: 10.1186/s12888-014-0347-z) (PMID:25551365) (PMCID:PMC4302079)

Boyer, N. , Boyd, K. A. , Turner-Halliday, F., Watson, N. and Minnis, H. (2014) Examining the feasibility of an economic analysis of dyadic developmental psychotherapy for children with maltreatment associated psychiatric problems in the United Kingdom. BMC Psychiatry, 14, 346. (doi: 10.1186/s12888-014-0346-0) (PMID:25492801) (PMCID:PMC4299309)

Tappin, D. et al. (2014) Financial incentives for smoking cessation during pregnancy: a randomised controlled trial. Lancet, 384, S4. (doi: 10.1016/S0140-6736(14)62130-9)

Boyd, K.A. , Briggs, A.H. , Bauld, L., Sinclair, L. and Tappin, D. (2014) Are financial incentives cost-effective for smoking cessation amongst pregnant women? European Journal of Public Health, 24(S2), p. 146. (doi: 10.1093/eurpub/cku162.090)

Tappin, D. , Bauld, L., Purves, D., Boyd, K. A. , Sinclair, L., MacAskill, S., McKell, J., Friel, B., McConnachie, A. and Coleman, T. (2014) Cessation in Pregnancy Incentives Trial (CPIT): a phase II trial in Scotland 2011-2013. European Journal of Public Health, 24(S2), p. 183. (doi: 10.1093/eurpub/cku163.071)

Boyd, K.A. , Jones, R.J. , Paul, J. , Briggs, A. and Leung, H.Y. (2014) A decision-analytic cost-effectiveness model to compare treatment options for radiation recurrent prostate cancer against androgen deprivation therapy. British Journal of Surgery, 101(s4), p. 59. (doi: 10.1002/bjs.9510)

Pritchett, R. et al. (2013) A feasibility randomised controlled trial of the New Orleans intervention of infant mental health: a study protocol. Scientific World Journal, 2013(838042), (doi: 10.1155/2013/838042)

Ferguson, J., Docherty, G., Bauld, L., Lewis, S., Lorgelly, P., Boyd, K.A. , McEwen, A. and Coleman, T. (2012) Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial. British Medical Journal, 344, e1696. (doi: 10.1136/bmj.e1696)

Roberts, N.J., Boyd, K. , Briggs, A.H. , Caress, A.L. and Partridge, M.R. (2012) Nurse led versus lay educators support for those with asthma in primary care: a costing study. BMC Pulmonary Medicine, 12(52), (doi: 10.1186/1471-2466-12-52)

Tappin, D.M. et al. (2012) The cessation in pregnancy incentives trial (CPIT): study protocol for a randomized controlled trial. Trials, 13(113), (doi: 10.1186/1745-6215-13-113) (PMID:22818493) (PMCID:PMC3482147)

Watterson, A., Little, D., Young, J.A., Murray, F., Doi, L., Boyd, K.A. and Azim, E. (2012) Scoping a public health impact assessment of aquaculture with particular reference to tilapia in the UK. ISRN Public Health, 2012, pp. 1-18. (doi: 10.5402/2012/203796)

Boyd, K.A. , Briggs, A.H. , Fenwick, E., Norrie, J. and Stock, S. (2011) Power and sample size for cost-effectiveness analysis: fFN neonatal screening. Contemporary Clinical Trials, 32(6), pp. 893-901. (doi: 10.1016/j.cct.2011.07.007)

Brush, J. et al. (2011) The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Health Technology Assessment, 15(35), pp. 1-192. (doi: 10.3310/hta15350)

Bauld, L., Boyd, K. A. , Briggs, A. H. , Chesterman, J., Ferguson, J., Judge, K. and Hiscock, R. (2011) One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine and Tobacco Research, 13(2), pp. 135-145. (doi: 10.1093/ntr/ntq222)

Boyd, K.A. , Briggs, A. , Paul, J. , Iveson, T., Midgely, R., Harkin, A., Bates, G., Alexander, L. and Cassidy, J. (2011) Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting? Trials, 12, A41. (doi: 10.1186/1745-6215-12-S1-A41)

Boyd, K.A. , Fenwick, E. and Briggs, A. (2010) Using an iterative approach to economic evaluation in the drug development process. Drug Development Research, 71(8), pp. 470-477. (doi: 10.1002/ddr.20421)

Young, J.A., Little, D.C., Watterson, A., Murray, F., Boyd, K. , Leschen, W. and Kodithuwakku, S. (2010) Growing green: the emergent role of non-tilapia attributes in marketing tilapia. Aquaculture: Economics and Management, 14(1), pp. 63-79. (doi: 10.1080/13657300903566886)

Boyd, K.A. and Briggs, A.H. (2009) Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow. Addiction, 104(2), pp. 317-325. (doi: 10.1111/j.1360-0443.2008.02449.x)

Belton, B., Little, D. and Grady, K. (2009) Is responsible aquaculture sustainable aquaculture? WWF and the eco-certification of Tilapia. Society and Natural Resources, 22(9), pp. 840-855. (doi: 10.1080/08941920802506257)

Little, D.C., Murray, F.J., Azim, E., Leschen, W., Boyd, K. , Watterson, A. and Young, J.A. (2008) Options for producing a warm-water fish in the UK: limits to 'Green Growth'? Trends in Food Science and Technology, 19(5), pp. 255-264. (doi: 10.1016/j.tifs.2007.12.003)

Watterson, A., Little, D., Young, J.A., Boyd, K., Azim, E. and Murray, F. (2008) Towards integration of environmental and health impact assessments for wild capture fishing and farmed fish with particular reference to public health and occupational health dimensions. International Journal of Enviromental Health Research, 5(4), pp. 258-277. (doi: 10.3390/ijerph5040258)

Book Sections

Squires, H. and Boyd, K. (2019) Use of modelling in the economic evaluation of public health interventions. In: Edwards, R. T. and McIntosh, E. (eds.) Applied Health Economics for Public Health Practice and Research. Series: Handbooks in health economic evaluation. Oxford University Press. ISBN 9780198737483

Boyd, K. and Briggs, A. (2013) Statistical issues with trial data and economic modeling for cost-effectiveness evaluation. In: Tang, W. and Tu, X. (eds.) Modern Clinical Trial Analysis. Series: Applied bioinformatics and biostatistics in cancer research. Springer-Verlag: New York, NY, USA, pp. 149-166. ISBN 9781461443216 (doi: 10.1007/978-1-4614-4322-3_6)

Research Reports or Papers

Minnis, H. et al. (2024) Prioritising early childhood to promote the nation’s health, wellbeing and prosperity. Working Paper. Academy of Medical Sciences.

Dillon, J. F. et al. (2018) A pilot evaluation of an intelligent liver diagnostic pathway: Making sense of LFTs for patients, GPs and the NHS in Scotland. Project Report. Chief Scientist Office, Edinburgh.

Conference or Workshop Item

Heggie, R., Boyd, K. , Horne, M., Bruijn, M., Stock, S. and on behalf of the QUIDS research team, . (2020) When should we admit for preterm labour? An economic evaluation of the QUIDS prognostic model. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

Heggie, R., Wu, O. , Boyd, K. , Lee, M. M.Y., Petrie, M. C. , McEntegart, M. and Berry, C. (2020) Does routine invasive management benefit patients presenting with an acute coronary syndrome and a history of bypass surgery? The use of clinical outcomes compared with cost-effectiveness outcomes. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

Boyd, K. , Dillon, J., Inglis, S. and Rezaeihemami, M. (2018) Making Sense of Liver Function Tests: Is the Intelligent Liver Function Test (iLFT) Cost-Effective? The International Liver Congress 2018, Paris, France, 11-15 Apr 2018. ISBN 0168-8278 (doi: 10.1016/S0168-8278(18)31885-3)

Haghpanahan, H. , Boyd, K.A. , Mackay, D.F. , Mcintosh, E. , Pell, J. and Haw, S. (2017) The Effectiveness and Cost-Effectiveness of Tobacco Control Mass Media Campaigns In Scotland. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. (doi: 10.1016/j.jval.2017.08.007)

Heggie, R., Boyd, K. , Stock, S. and Bruijn, M. (2017) How Should We Test For Pre-Term Labour? An Economic Model And Cost-Effectiveness Analysis. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. A600. (doi: 10.1016/j.jval.2017.08.1143)

Kohli-Lynch, C.N. , Boyd, K. , Briggs, A. and Delles, C. (2017) A Framework for the Cost-Effectiveness Analysis of Novel Biomarker Testing in Cardiovascular Disease. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. A404-A405. (doi: 10.1016/j.jval.2017.08.040)

Rezaei Hemami, M., Boyd, K.A. , Inglis, S.K., Dow, E. and Dilon, J.F. (2017) Cost Effectivness Of Inteligent Liver Function Test(ILFT) For Investigating Patients With Abnormal Liver Function Test. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. A597. (doi: 10.1016/j.jval.2017.08.1129)

Iveson, T. et al. (2017) Final DFS Results of the SCOT study: An International Phase III Randomised (1:1) Non-Inferiority Trial Comparing 3 Versus 6 Months of Oxaliplatin Based Adjuvant Chemotherapy for Colorectal Cancer. 42nd ESMO 2017 Congress, Madrid, Spain, 8-12 Sept 2017.

Lawless, C.A. et al. (2017) ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). UNSPECIFIED S80-S81. (doi: 10.1016/S0169-5002(17)30221-0)

This list was generated on Thu Apr 18 22:55:55 2024 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • A pilot randomised controlled trial of sleep restriction therapy versus sleep hygiene education for newly diagnosed breast cancer patients with acute insomnia
    Office of the Chief Scientific Adviser
    2023 - 2025
     
  • What works for Children's Social Care
    What Works for Children's Social Care
    2022 - 2023
     
  • Maximising the public health benefits of smokefree prisons
    National Institute for Health Research
    2021 - 2023
     
  • Economic analysis for Evaluation of Linked Workers Programme
    Office of the Chief Scientific Adviser
    2021 - 2024
     
  • A phase II RCT to measure the cost and consequences of Dyadic Developmental Psychotherapy compared with 'usual treatment' for children referred with maltreatment-associated psychiatric problems
    National Institute for Health Research
    2020 - 2024
     
  • Outpatient cervical ripening for induction of labour
    National Institute for Health Research
    2019 - 2022
     
  • BALLAD- A global study to evaluate the potential benefit of adjuvant chemotherapy for small bowel andenocarcinoma (International Rare Cancers Initiative study-IRCI 002)
    Cancer Research UK (CRUK)
    2018 - 2019
     
  • BALLAD- A global study to evaluate the potential benefit of adjuvant chemotherapy for small bowel andenocarcinoma (International Rare Cancers Initiative study-IRCI 002)
    Cancer Research UK
    2018 - 2020
     
  • The Smoking Cessation in Pregnancy Incentives Trial
    Public Health Agency
    2018 - 2020
     
  • Evaluating graduated progress towards and impacts of the implementation of indoor smoke free prison facilities in Scotland (TIPS)
    National Institute for Health Research
    2018 - 2020
     
  • SYSTEMS 2: A randomized Phase II trial of standard versus does escalated radiotherapy in the treatment of pain in malignant pleural mesothelioma
    The London Community Foundation
    2017 - 2018
     
  • Evaluating graduated progress towards an indoor smoke free prison facilities in Scotland
    National Institute for Health Research
    2016 - 2019
     
  • QUIDS INFOED: 032842
    National Institute for Health Research
    2016 - 2019
     
  • The Best Services Trial: Effectiveness and cost-effectiveness of the New Orleans Intervention Model for Infant Mental Health (BeST 2)
    National Institute for Health Research
    2016 - 2021
     
  • Extension of Follow-Up for High Risk Stage II Patients (additional 3 years) and Stage III Patients (up to year 3 follow-up) in the SCOT study.
    National Institute for Health Research
    2015 - 2018
     
  • SYSTEMS 2: A randomized Phase II trial of standard versus does escalated radiotherapy in the treatment of pain in malignant pleural mesothelioma
    Beatson Cancer Charity
    2015 - 2018
     
  • A pilot evaluation of an intelligent liver diagnostic pathway: Making sense of LFTs for patients, GPs and the NHS in Scotland
    Chief Scientist Office
    2015 - 2017
     
  • SYSTEMS 2: A randomized Phase II trial of standard versus does escalated radiotherapy in the treatment of pain in malignant pleural mesothelioma
    June Hancock Mesothelioma Research Fund
    2014 - 2017
     
  • BALLAD - A global study to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma.
    Cancer Research UK
    2013 - 2018
     
  • BALLAD - A global study to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma (International Rare Cancers Initiative study - IRCI 002)
    Cancer Research UK
    2013 - 2023
     
  • Evaluation of the New Orleans Intervention Project for Infant Mental Health in Glasgow
    National Society for Prevention of Cruelty to Children
    2013 - 2018
     
  • Partnership Endowment Funds - UK mapping and modelling for a definitive randomised controlled trial of the New Orleans Intervention for Infant Mental Health.
    NHS Greater Glasgow and Clyde Endowment Funds
    2013 - 2015
     
  • Evaluation of the New Orleans Intervention Project for Infant Mental Health in Glasgow
    Chief Scientist Office
    2012 - 2015
     
  • Scoping service delivery and the CMA for children at risk of neglect.
    NHS Greater Glasgow and Clyde
    2012 - 2012
     
  • Evaluation of the New Orleans Intervention Project for Infant Mental Health in Glasgow
    NHS Greater Glasgow & Clyde
    2012 - 2012
     
  • New Orleans Intervention Model: RA
    National Society for Prevention of Cruelty to Children
    2011 - 2015
     
  • Value of information analysis of TAVI
    National Institute for Health Research
    2011 - 2011
     

Supervision

SUPERVISION - Current

  • Yuejiao Duan,  August 2021 – present 
  • Fabiola Lemus Villafuert,  Oct 2020 – present
  • TzuJung Lai, Oct 2019 – present

Lai, Tzu Jung

Challenges of Medical Device Assessment Methodology

  • Duan, Yuejiao
    Economic evaluation of drug-related harm reduction programs
  • Lai, Tzu Jung
    How can Health Technology Assessment (HTA) support the optimal use of high-cost devices? A case study of robotic-assisted surgery in Scotland
  • Lemus Villafuerte, Fabiola
    Institute of Health & Wellbeing
  • Wang, Qiuyang
    Using health technology assessment to solve the problems of reimbursement decision and accessibility of rare disease treatments - a case study of spinal muscular atrophy (SMA)
  • Wattanasukchai, Luxzup
    A cost-effectiveness of ultrasonographic screening programme for cholangiocarcinoma in Thailand

SUPERVISON - Completed

Robert Heggie - 2023

Incorporating implementation within the economic evaluation of health technologies. 

Catherine Hannah - 2021

Cancer clinical trials: identifying & testing approaches to impact evaluation

Saowalak Turongkaravee: August 2019 - 2021, Visiting PhD student

Ong The Due: September 2019 - 2020, Visiting PhD student

Ciaran Kohli-Lynch - 2019

Beyond ten-year risk: novel approaches to the primary prevention of cardiovascular disease

Nicole Boyer - 2018

Economic evaluation of population health interventions aimed at children and delivered at school 

Tadesse Gebrye - 2018

Cost-effectiveness analysis and modelling the lifetime costs and benefits of health behaviour interventions on Diabetes

 

Teaching

I co-ordinate the CPD and MSc HTA module 'Advanced Economic Evaluation Methods' (AEEM), support the Health Economics for Health Technology Assessment module on the MSc for HTA and supervise a variety of post graduate research projects. I have a record of reflective, reasoned and innovative approaches to teaching, course design, assessment and evaluation and contribute to PGR learning and teaching as well as CPD course development and teaching.

Research datasets

Jump to: 2019
Number of items: 1.

2019

Paul, J. , Boyd, K. , Briggs, A. , Cassidy, J., Harkin, A. and Iveson, T. (2019) The 'Short Course Oncology Treatment' (SCOT) trial. [Data Collection]

This list was generated on Thu Apr 18 22:55:57 2024 BST.

Professor Kathleen A Boyd